Rs 1,960 Puts — 1.3% Below Current Price — Draw 2,455 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

The 28 July expiry saw significant put option turnover in Sun Pharmaceutical Industries Ltd, with 2,455 contracts traded at the Rs 1,960 strike. The open interest at this strike stands at 2,337 contracts, indicating that much of this activity represents fresh positioning rather than mere rollovers or adjustments. The total turnover for these puts was approximately ₹3.61 crores, signalling meaningful market interest.

The stock itself has been on a positive trajectory, hitting a new 52-week and all-time high of Rs 1,988.8 on the same day. It has outperformed its sector by 0.51% and gained 2.26% over the past two days, trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day. Delivery volumes surged to 49.93 lakh shares on 27 July, a 260.62% increase over the five-day average, reflecting strong investor participation in the rally. Is this put activity a sign of protective hedging amid a strong rally, or does it hint at underlying caution?

Strike Price Analysis: Moneyness and Intent

The Rs 1,960 strike sits approximately 1.3% below the current market price of Rs 1,986.2, placing these puts slightly out-of-the-money (OTM). This proximity to the underlying price is critical in interpreting the intent behind the trades. OTM puts close to the money are often purchased as a form of insurance to protect gains in a rising stock, rather than as outright bearish bets expecting a sharp decline.

Given the stock’s recent upward momentum and the strike’s closeness, the put buyers may be seeking downside protection against a potential pullback rather than anticipating a sustained drop below Rs 1,960. Alternatively, some of this activity could represent put writing, where sellers collect premium betting the stock will remain above this level, but the open interest and turnover ratios suggest more buying interest than selling pressure.

How does the strike distance combined with the stock’s technical strength clarify the nature of this put activity?

Interpreting the Put Activity: Hedging, Bearish Positioning, or Put Writing?

Put options inherently carry ambiguous signals. They can indicate bearish positioning if bought as a directional bet expecting a decline, protective hedging if bought to guard existing long positions, or put writing if sold to collect premium in a bullish scenario. In this case, the stock’s recent gains and strong technicals weigh against a purely bearish interpretation.

The Rs 1,960 puts being just below the current price and the stock trading above all major moving averages suggest that the put buyers are more likely hedging their long exposure. This is a common strategy when a stock has rallied sharply and investors seek to limit downside risk without exiting positions. The alternative, bearish directional bets, would typically involve at-the-money or in-the-money puts during a downtrend, which is not the case here.

Put writing is less likely given the open interest of 2,337 contracts is close to the number of contracts traded (2,455), indicating fresh buying rather than premium collection. The turnover and open interest ratio of roughly 1:1 supports this view. Could this put activity be signalling a cautious optimism rather than outright bearishness?

Open Interest and Contracts Analysis

The open interest of 2,337 contracts at the Rs 1,960 strike is nearly equal to the 2,455 contracts traded on the day, indicating that most of the activity represents new positions rather than closing trades. This suggests a significant fresh interest in downside protection or speculative put buying.

The ratio of contracts traded to open interest is approximately 1.05:1, which is relatively balanced and does not point to aggressive unwinding or put writing. This contrasts with call option markets where higher ratios often indicate speculative bursts. The data here implies measured positioning, consistent with hedging strategies rather than panic selling or aggressive bearish bets.

Cash Market Context: Technicals and Delivery Volumes

Sun Pharmaceutical Industries Ltd is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — a technical configuration that typically signals strength and investor confidence. The stock’s recent 2.26% gain over two days and new 52-week high reinforce this positive momentum.

Delivery volumes have surged dramatically, with 49.93 lakh shares delivered on 27 July, a 260.62% increase over the five-day average. This rise in delivery volume suggests genuine investor participation in the rally rather than speculative intraday moves. However, the put activity may reflect a prudent approach to risk management amid this strong but potentially volatile advance.

Does the combination of rising delivery volumes and put buying indicate a market balancing optimism with caution?

Fundamental and Market Capitalisation Context

Sun Pharmaceutical Industries Ltd is a large-cap company with a market capitalisation of approximately ₹4,76,028 crore. Operating in the Pharmaceuticals & Biotechnology sector, the company’s fundamentals have supported steady investor interest, reflected in its sustained price appreciation and liquidity. The stock’s ability to maintain gains above all major moving averages aligns with its large-cap status and sector resilience.

Conclusion: Protective Hedging Amid Strength

The Rs 1,960 put option activity on Sun Pharmaceutical Industries Ltd appears to be predominantly protective hedging rather than outright bearish positioning. The strike price’s proximity to the current price, combined with the stock’s recent rally, strong technicals, and rising delivery volumes, supports this interpretation.

While put buying can sometimes signal bearish conviction, in this case, the data suggests investors are managing risk amid a strong uptrend rather than anticipating a sharp decline. The open interest and turnover ratios further reinforce the view of measured, fresh positioning consistent with downside protection.

With puts active and the stock trading above all key moving averages, should investors consider hedging their positions in Sun Pharmaceutical Industries Ltd or view the rally as sustainable?

Key Data at a Glance

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →